Who founded Purigen Biosystems, Inc.?

Purigen Biosystems, Inc. was founded by Bill W. Colston, Ph.D., Klint Rose, Ph.D. in 2012.

Who are Purigen Biosystems, Inc.'s investors?

Purigen Biosystems, Inc.'s investors include 5AM Ventures, Cota Capital, Roche Venture Fund.

How much funding has Purigen Biosystems, Inc. raised?

Purigen Biosystems, Inc. has disclosed $61.1M raised across 3 rounds.

Where is Purigen Biosystems, Inc. headquartered?

Purigen Biosystems, Inc. is headquartered in Pleasanton, US.

Purigen Biosystems, Inc.

Pleasanton, US · Founded 2012 · Delaware corporation · 3 known investors

Biotech

Founders & leadership

Purigen Biosystems, Inc. was founded in 2012 by Bill W. Colston, Ph.D. and Klint Rose, Ph.D..

Bill W. Colston, Ph.D.Co-founder

Klint Rose, Ph.D.Chief Scientific Officer

Barney E. Saunders,Ph.D.Chief Executive Officer

Steve ReichenbachChief Financial Officer

Joseph J. VictorExecutive Chairman of the Board of DirectorsVenture Advisor at 5AM Ventures

Juan G. SantiagoNamed on SEC filing

Klint RoseNamed on SEC filing

Amy HiddessenNamed on SEC filing

Board

Mira Chaurushiya, Ph.D.Board director

Kevin CorcoranBoard director

Investors · 3

5AM Venturesreported · 2 sourcesBoston · $100K – $4Mvia Joseph J. Victor · board

Cota CapitalreportedSan Francisco

Roche Venture FundreportedBasel · $648K – $3.2M

Reported raises · per SEC filings

Form D private placements

$61.1M disclosed across 3 rounds · 2014–2019

▶$34.4MraisedApr 2021 · 16 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Barney E. Saunders,Ph.D.Executive Officer, Director
Steve ReichenbachExecutive Officer
Bill W. Colston, Ph.D.Director
Mira Chaurushiya, Ph.D.Director
Kevin CorcoranDirector
Klint Rose, Ph.D.Executive Officer
Joseph J. VictorDirector

Offering amount: $34.4M
Amount sold: $34.4M
First sale: Mar 2019
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$26.4MraisedJun 2018 · 28 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Barnett SaundersExecutive Officer, Director
Joseph VictorDirector
Mitchell MutzDirector
Klint RoseExecutive Officer, Promoter
Steve ReichenbachExecutive Officer
Andrew SchwabDirector
Juan SantiagoPromoter
Bill W. ColstonDirector

Offering amount: $30.8M
Amount sold: $26.4M
First sale: Mar 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$200KraisedAug 2014 · 5 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Juan G. SantiagoExecutive Officer, Director, Promoter
Klint RoseExecutive Officer, Director, Promoter
Amy HiddessenExecutive Officer, Director, Promoter

Offering amount: $1.7M
Amount sold: $200K
First sale: Jul 2014
Incorporated: Corporation, Delaware, 2012
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Purigen Biosystems, Inc. announced that it has received $26.4 million in funding from Agilent Technologies, Inc., Cota Capital Management LLC, 5AM Venture Management, LLC, Roche Venture Fund | MarketScreenermarketscreener.com · Jun 2019

Purigen Biosystems Raises $26.4 Million Series B Financing to Accelerate Commercialization of Automated Sample Preparation Platform - BioSpacebiospace.com · Jun 2019

Frequently asked questions

Who founded Purigen Biosystems, Inc.?: Purigen Biosystems, Inc. was founded by Bill W. Colston, Ph.D., Klint Rose, Ph.D. in 2012.
Who are Purigen Biosystems, Inc.'s investors?: Purigen Biosystems, Inc.'s investors include 5AM Ventures, Cota Capital, Roche Venture Fund.
How much funding has Purigen Biosystems, Inc. raised?: Purigen Biosystems, Inc. has disclosed $61.1M raised across 3 rounds.
Where is Purigen Biosystems, Inc. headquartered?: Purigen Biosystems, Inc. is headquartered in Pleasanton, US.